High‑dose intravenous methylprednisolone therapy in patients with Graves’ orbitopathy is associated with the increased activity of factor VIII

Jul 5, 2018 | Articulo Comentado Endo-Adulto, Articulos Comentados

Miśkiewicz P, Milczarek‑Banach J, Rutkowska‑Hinc B, Kondracka A, Bednarczuk T.
Journal of Endocrinological Investigation.
https://doi.org/10.1007/s40618-018-0907
Ver comentario
Comentado por Dra. Pamela Invernizzi B. y Dra. Vjerocka Inostroza S. Residentes Endocrinología Adulto, Hospital San Juan de Dios.